Variations in breast cancer incidence per decade of life (Goiânia, GO, Brazil): 16-year analysis

Cancer Causes and Control

Volumn 19, Issue 7, 2008, Pages 681-687

  Freitas Junior, Ruffo ^a   Freitas, Nilceana Maya Aires ^b   Curado, Maria Paula ^c,d   Martins, Edesio ^c   Moreira, Marise Amaral Rebouças ^e   E Silva, Carleane MacIel Bandeira ^c  

^a Araujo Jorge Hospital   (Brazil)

^b Araújo Jorge Hospital   (Brazil)

^c Goiania Cancer Registry   (Brazil)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Age groups; Brazil; Breast cancer; Epidemiology; Goi nia; Incidence

Indexed keywords

CESIUM 137;

ADULT; AGED; AGING; ARTICLE; BRAZIL; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR ACCIDENT; PRIORITY JOURNAL; RADIATION EXPOSURE;

ACCIDENTS, RADIATION; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; REGISTRIES; SURVIVORS;

EID: 48149085698     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9131-z     Document Type: Article

References (34)

1. Abeloff MD, Wolff AC, Wood WC, Mccormick B, Weber BL (2004) Cancer of the breast. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Clinical oncology, 3rd edn. Elsevier, Philadelphia, pp 2369-2470
2. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405-412
3. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N (2005) Model of outcomes of screening mammography: information to support informed choices. Br Med J 330:936-941
4. Parkin DM, Bray FI, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74-108
5. Suzuki T, Toi M, Saji S et al (2006) Early breast cancer. Int J Clin Oncol 11:108-119
6. Ziegler RG, Hoover RN, Pike MC et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819-1827
7. Mcgregor DH, Land CE, Choi K et al (1977) Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. J Natl Cancer Inst 59:799-811
8. IAEA-International Atomic Energy Agency (1988) The radiological accident in Goiania. Vienna, STI-PUB 815, 1988
9. Freitas NMA, Freitas R Jr, Curado MP et al (2006) Tendência da incidência e da mortalidade do câncer de mama em Goiânia: análise de 15 anos (1988-2002). Rev Bras Mastol 16:17-22
10. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4-S66
11. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon
12. Paulinelli RR, Freitas R Jr, Curado MP, Souza AA (2003) A situação do câncer de mama em Goiás, no Brasil e no mundo: tendências atuais para a incidência e a mortalidade. Rev Bras Saúde Matern Infant 3:17-24
13. Curado MP, Latorre MRDO (2000) Câncer em Goiânia: tendências (1988-1997). Max Gráfica, Goiânia
14. Pereira MG (2000) Epidemiologia teoria e prática. 4a reimpres. Guanabara Koogan, Rio de Janeiro
15. IBGE-Instituto Brasileiro de Geografia e Estatística. Diretoria e Pesquisa. Departamento de População e Indicadores Sociais. População residente-Censo 2000: Brasil, unidades da federação e municípios, 2000. Available at: http://www.ibge.gov.br/ (2007; Jun 26)
16. Segi M (1960) Cancer mortality for selected sites in 24 countries (1950-57). Tohoku University of Medicine, Sendai, Japan
17. Jemal A, Rebecca S, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106-130
18. Kerlikowske K, Grady D, Rubin SM et al (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273:149-154
19. Shapiro S, Venet W, Strax P et al (1985). Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 67:65-74
20. Sondik EJ (1994) Breast cancer trends. Incidence, mortality, and survival. Cancer 74:995-999
21. Taplin SH, Ichikawa L, Buist DSM, Seger D, White E (2004) Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Bio Prev 13:225-234
22. Collaborative Group On Hormonal Factors In Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50.302 women with breast cancer and 96,973 women without the disease. Lancet 360:187-195
23. Minami Y, Ohuchi N, Fukao A et al (1977) Risk factors for breast cancer: a case-control study of screen-detected breast cancer in Miyagi prefecture, Japan. Breast Cancer Res Treat 44:225-233
24. Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762-771
25. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G (2005) Breast cancer. Lancet 365:1727-1741
26. Russo J, Russo IH (1993) Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2(suppl 3):85-100
27. Barros ACSD (2006) Genética, biologia molecular e carcinogênese mamária. Rev Bras Mastol 16:78-85
28. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
29. Milanese TR, Hartmann LC, Sellers TA et al (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600-1607
30. Writing Group For The Women's Health Initiative Investigators (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
31. Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427
32. Ravdin PM, Cronin KA, Howlander N, Chlebowski RT, Berry DA (2006) A sharp decrease in breast cancer incidence in the United States in 2003. Breast Cancer Res Treat 100(suppl 1):S6
33. Wei F, Miglioretti DL, Connelly MT et al (2005) Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 35:106-112
34. Clarke CA, Glaser SL (2006) Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 24:e49-e50